It was recently noticed that an error had been made in the research article by Ljuslinder and colleagues \[[@B1]\] published by *Breast Cancer Research*in July 2005. The legend of Table [4](#T1){ref-type="table"} was incorrect and should read as featured opposite.
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EGFR and ERBB2 quantitative RT-PCR mRNA results in eight patients and matched controls (group B)

  Patient number   T        NN       T/NN^a^
  ---------------- -------- -------- ---------
  1^b^                               
   EGFR            4,677    12,493   0.37
   ERBB2           24,066   21,817   1.1
  2^b^                               
   EGFR            3,321    14,519   0.22
   ERBB2           61,389   6,666    9.2
  4                                  
   EGFR            20,778   14,842   1.39
   ERBB2           9,143    6,742    1.35
  5^b^                               
   EGFR            9,730    15,867   0.61
   ERBB2           13,506   3,056    4.41
  6                                  
   EGFR            1,305    15,871   0.08
   ERBB2           10,677   10,080   1.06
  7                                  
   EGFR            1,024    12,162   0.08
   ERBB2           7,639    5,871    1.30
  8^b^                               
   EGFR            4,936    28,111   0.17
   ERBB2           17,106   9,263    1.85
  9                                  
   EGFR            5,540    1,437    3.85
   ERBB2           7,330    5,540    1.32

^a^T/NN: mRNA expression levels of EGFR/ERBB2 in tumour tissue (T) samples divided by values in in matched non-neoplastic (NN) tissue samples. As described in the results, at p.9, ratios \> 1. 2 are regarded as significant overexpression and ratios \< 0. 8 are regarded as significant underexpression in neoplastic tissue compared to non-neoplastic tissue. ^b^Patients with increased *LRIG1*copy number. No RNA from patient 3 was available for EGFR/ERBB2 analysis.
